Form 8-K - Current report:
SEC Accession No. 0001564590-22-015078
Filing Date
2022-04-21
Accepted
2022-04-21 16:10:40
Documents
13
Period of Report
2022-04-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 Q1 2022 PR 8-K pstv-8k_20220421.htm   iXBRL 8-K 31423
2 EX-99.1 pstv-ex991_6.htm EX-99.1 355588
  Complete submission text file 0001564590-22-015078.txt   534029

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pstv-20220421.xsd EX-101.SCH 5621
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20220421_lab.xml EX-101.LAB 19329
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20220421_pre.xml EX-101.PRE 11510
7 EXTRACTED XBRL INSTANCE DOCUMENT pstv-8k_20220421_htm.xml XML 3548
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 22841512
SIC: 3841 Surgical & Medical Instruments & Apparatus